In summary, the role of IL-1RA in thyroid cancer is similar to that of other cancers, although it also has its own unique pathway and mechanism, which provides a theoretical basis for its use as a potential therapeutic target. The gene discussed is IL1RN; the disease is thyroid gland carcinoma.